CELK AB Stock Nasdaq Stockholm
Equities
SE0009189657
Advanced Medical Equipment & Technology
Sales 2024 * | 2.43B 231M 0 | Sales 2025 * | 2.78B 265M 0 | Capitalization | 3.06B 292M 0 |
---|---|---|---|---|---|
Net income 2024 * | -74M -7.05M - | Net income 2025 * | -16M -1.52M - | EV / Sales 2024 * | 1 x |
Net cash position 2024 * | 630M 60.05M 0 | Net cash position 2025 * | 311M 29.61M 0 | EV / Sales 2025 * | 0.99 x |
P/E ratio 2024 * |
-41
x | P/E ratio 2025 * |
-189
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.54% |
Latest transcript on CELK AB
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | Nov. 19 | |
Director of Finance/CFO | 39 | 21-11-30 | |
Marius Balger
COO | Chief Operating Officer | 56 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
CHM | Chairman | 79 | 22-04-25 |
John Mackay
BRD | Director/Board Member | 62 | 22-12-31 |
Director/Board Member | 68 | 19-12-17 |
1st Jan change | Capi. | |
---|---|---|
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.37% | 64.16B | |
+19.45% | 54.88B | |
-2.27% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |